Healthcare -
Biotechnology - NASDAQ - US
$ 47.58
-3.14 %
$ 3.57 B
Market Cap
-12.69
P/E
AKRO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities AKRO - Akero Therapeutics, Inc.
353 M
LAST VALUE
2322.61%
2 YEAR CAGR
32.97%
5 YEAR CAGR
0.00%
10 YEAR CAGR